Table of Contents

The Goals of Competition Law

The Goals of Competition Law

ASCOLA Competition Law series

Edited by Daniel Zimmer

What are the normative foundations of competition law? That is the question at the heart of this book. Leading scholars consider whether this branch of law serves just one or more than one goal, and, if it serves to protect unfettered competition as such, how this goal relates to other objectives such as the promotion of economic welfare.

Chapter 17: Goals of Union Competition Law on Regulated Markets: Pharmaceutical Industry and Parallel Trade – Comment on Negrinotti

Lubos Tichy

Subjects: economics and finance, law and economics, law - academic, competition and antitrust law, law and economics


Luboš Tichý* 1 INTRODUCTION These short remarks serve as a brief analysis of the recent development in the evaluation of limitations to parallel business in regards to competition rules. This is an issue concerning the basic orientation of the competition law of the European Union. At its foundation lies the question to what extent it is necessary to take into consideration the welfare of the consumer as one of the main goals or even as the single main goal of competition rules in the application and focus of the rules, on the one specific market, which is, especially in regards to the interest of the final consumer, regulated by the individual states – the market of pharmaceutical products. The focus of our analysis is on the decisions of the European Commission,  the Tribunal and the European Court of Justice of recent years.1 I will conduct the analysis against the backdrop of existing judicature, as well as of the basic values of the competition law of the Union. I will proceed by first delineating the basic framework of values in which the competition rules function (section 2). I will deal with the basic orientation of competition law and competition policy: their goals and the relationship of competition rules with the fundamental freedoms of the EU (section 3). Then I will verify two relevant aspects (sections 4 and * Prof Dr, Director of the Centre for Comparative Law of the Charles University in Prague. 1 Case T-168/01, GlaxoSmithKline v Commission; Joined cases C-501/06, C-513/06,...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information